Concepts represent early planning stages for program announcements, requests for applications, notices of special interest, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.
NB: Council approval does not guarantee that a concept will become an initiative.
Table of Contents
Fiscal Year (FY) 2023 Concepts
- Diagnostics Preclinical Services Program
- Biological and Emerging Infections Research Resources Program (BEI-RRP)
- Preclinical Services for Biopharmaceutical Product Development
- Partnerships for Rapid Diagnostics and Phenotypic Antibacterial Susceptibility Testing for Bacteremia or Hospital Acquired Pneumonia
- Improved Drug Susceptibility Testing (DST) for Tuberculosis
- Biocontainment Laboratory Support for Pandemic Preparedness
Diagnostics Preclinical Services Program
Request for Proposals—proposed FY 2023 initiative
For the published request for proposals, check the April 15, 2022 solicitation, Diagnostics Preclinical Services Program.
Biological and Emerging Infections Research Resources Program (BEI-RRP)
For the published request for proposals, check the December 23, 2021 solicitation, The Biological and Emerging Infections Research Resources Program (BEI-RRP).
Preclinical Services for Biopharmaceutical Product Development
For the published request for proposals, check the January 24, 2022 solicitation, Preclinical Services for Biopharmaceutical Product Development.
Partnerships for Rapid Diagnostics and Phenotypic Antibacterial Susceptibility Testing for Bacteremia or Hospital Acquired Pneumonia
For the published request for applications, check the February 23, 2022 Guide notice, Partnerships for Rapid Diagnostics and Phenotypic Antibacterial Susceptibility Testing for Bacteremia or Hospital Acquired Pneumonia (R01, Clinical Trial Not Allowed).
Improved Drug Susceptibility Testing (DST) for Tuberculosis
For the published request for applications, check the March 2, 2022 Guide announcement, Improved Drug Susceptibility Testing (DST) for Tuberculosis (R01, Clinical Trial Not Allowed).
Biocontainment Laboratory Support for Pandemic Preparedness
For the published request for applications, check the March 11, 2022 Guide announcement, Emergency Awards—Biocontainment Facility Improvements and Building System Upgrades To Support Pandemic Preparedness (G20, Clinical Trial Not Allowed).